Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
496 hedge funds and large institutions have $10.5B invested in Abiomed Inc in 2022 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 188 increasing their positions, 153 reducing their positions, and 60 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 188 | Existing positions reduced: 153
10% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 60
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less funds holding
Funds holding: 500 → 496 (-4)
24% less capital invested
Capital invested by funds: $13.8B → $10.5B (-$3.32B)
28% less call options, than puts
Call options by funds: $40.6M | Put options by funds: $56.5M
Top Buyers
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$101M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$59.4M |
| 3 |
Morgan Stanley
New York
|
+$44.8M |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$31.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$28.7M |
Top Sellers
ABMD Hedge Fund Activity: Q2 2022 in Review
496 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2022, worth a combined $10.5B — down 24% from $13.8B a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new ABMD positions and 60 closed out — a net gain of 6 holders — while 188 added to existing stakes and 153 trimmed.
The largest buyer was Winslow Capital Management, adding an estimated $101M. The largest seller was Wellington Management Group, cutting an estimated $194M.
- 496 institutional investors held Abiomed Inc (ABMD) as of Q2 2022, down from 500 in Q1 2022.
- Funds reported $10.5B of Abiomed Inc stock for Q2 2022, down 24% quarter-over-quarter.
- 66 funds opened new Abiomed Inc positions in Q2 2022 and 60 closed out, a net change of +6 holders.
- The largest Abiomed Inc buyer in Q2 2022 was Winslow Capital Management, an estimated $101M added.
- The largest Abiomed Inc seller in Q2 2022 was Wellington Management Group, an estimated $194M sold.
Based on aggregated 13F filings for Q2 2022.